News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ORTH ANDREW C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
4
| ORTH ANDREW C. (Chief Commercial Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 5,261 shares
@ $128.1045, valued at
$674k
Sold 6,906 shares
@ $128.9441, valued at
$890.5k
Sold 333 shares
@ $129.6972, valued at
$43.2k
Exercised 12,500 options to buy
@ $63.55, valued at
$794.4k
|
|
| 06/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/28/2023 |
4
| ORTH ANDREW C. (Chief Commercial Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 20,000 options to buy
@ $81.91, valued at
$1.6M
Granted 10,000 rights
@ $0 |
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|